ACC 2206 28 - 30 March 2026

Effect of oral semaglutide versus placebo on first and total MACE in SOUL trial participants with T2D and ASCVD and/or CKD

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.

Keywords

Diabetes

Congress poster

GLP-1 RA

Semaglutide (oral)

PHASE 3 (RCT)